Artivion to Participate in the 2026 Truist Securities MedTech Conference
10-06-2026 22:10 via prnewswire.com

Artivion to Participate in the 2026 Truist Securities MedTech Conference

ATLANTA, June 10, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate at the upcoming 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026, at the Boston Harbor...
Read more »

PR Public relations news



KT&G: "World's Largest Asset Manager BlackRock Increases stake from 5.01% to 6.15%"
KT&G: "World's Largest Asset Manager BlackRock Increases stake from 5.01% to 6.15%"
IHH Healthcare Collaborates with Infosys on a Multi-Country, AI-Powered ERP Transformation to Accelerate Growth
IHH Healthcare Collaborates with Infosys on a Multi-Country, AI-Powered ERP Transformation to Accelerate Growth
GLOB Investors Have Opportunity to Lead Globant S.A. Securities Fraud Lawsuit with the Schall Law Firm
GLOB Investors Have Opportunity to Lead Globant S.A. Securities Fraud Lawsuit with the Schall Law Firm
Sobi to present new clinical and real-world data at EHA 2026 in Stockholm
NatGold Digital Sets July 8 for NATG Global Trading Launch
NatGold Digital Sets July 8 for NATG Global Trading Launch
Sky Labs' 'CART BP pro' Expected to Be a Global 'Game Changer'
Sky Labs' 'CART BP pro' Expected to Be a Global 'Game Changer'
Sky Labs' „CART BP pro" von internationalen Experten als globaler „Game Changer" gewürdigt
Sky Labs' „CART BP pro" von internationalen Experten als globaler „Game Changer" gewürdigt
Se espera que el "CART BP pro" de Sky Labs se convierta en un auténtico "game changer" a nivel mundial
Se espera que el "CART BP pro" de Sky Labs se convierta en un auténtico "game changer" a nivel mundial
Le « CART BP pro » de Sky Labs, un véritable « game changer » à l'échelle mondiale
Le « CART BP pro » de Sky Labs, un véritable « game changer » à l'échelle mondiale
Hyundai Bioscience USA offers Free Drug Supply and Funding for Clinical Trials to WHO
Hyundai Bioscience USA offers Free Drug Supply and Funding for Clinical Trials to WHO
CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody) ASCO 2026 Key Highlights
DKSH Enters Strategic Distribution Partnership with BridgeBio to Support Regulatory Evaluation and Potential Patient Access to Transthyretin Stabilizer for ATTR-CM in Selected Asia Pacific Markets
Globant S.A. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - GLOB
UK, Australia, and Canada Announce Launch of Major New International Fund to Scale Civil Society and Tackle Root Causes of Israeli-Palestinian Conflict
UK, Australia, and Canada Announce Launch of Major New International Fund to Scale Civil Society and Tackle Root Causes of Israeli-Palestinian Conflict
Desktop versie